Key research themes
1. How can molecular imaging integrate with pathology to enable noninvasive, multiscale visualization of disease processes?
This research theme explores the emerging integration of molecular imaging techniques with traditional pathology to overcome limitations such as invasiveness and sample representativeness bias. The goal is to develop a ‘transpathology’ approach that combines molecular-level, in vivo imaging data with molecular histopathology towards a comprehensive, real-time visualization and characterization of disease states. This integration is poised to provide multiscale and dynamic assessment of pathophysiological changes at cellular and molecular levels, potentially transforming clinical diagnostics and patient management.
2. What technological advances in high-resolution and hybrid imaging modalities support comprehensive biomedical imaging for diagnosis and therapy?
This theme analyses innovations in imaging technologies—such as hybrid systems combining anatomical and functional imaging, high-resolution 3D imaging, and multispectral techniques—that increase diagnostic accuracy and facilitate image-guided interventions. Developments in instrumentation, data processing, and imaging physics enable multiparametric visualization of complex biological processes from macroscopic to molecular scales. These advances expand imaging capabilities beyond structure to include function, metabolism, and molecular activity in living tissues, underpinning precision medicine and personalized therapeutic strategies.
3. How can advanced imaging and artificial intelligence synergistically improve cancer diagnosis, biopsy guidance, and precision medicine?
This theme addresses the convergence of highresolution imaging modalities with machine learning/artificial intelligence techniques to enhance cancer detection, characterization, and interventional accuracy. It includes applications where imaging-derived quantitative features (radiomics and radiogenomics) inform disease phenotyping and prediction of treatment response. AI models applied to optical coherence tomography (OCT) and other imaging data can provide real-time biopsy guidance by assessing tissue morphology and cellularity, thereby reducing diagnostic errors and improving personalized therapy selection.